| Patient | Annie Oakley |
|---|---|
| Date of birth | 1961-08-13 |
| Identifiers | MRN HR-NI021-SYN; SSN (made up) 000-21-4806 |
| Document date | 2026-04-06 |
| Author | Ruth Ellingsen, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Eight-week pernicious anemia review, endoscopy results, and back pain review. [S]
Mrs. Oakley returns eight weeks after starting B12 replacement. She completed the four weekly injections four weeks ago, and her first monthly injection is given today. Her energy is back to normal, she climbs stairs without breathlessness, and her tongue has healed. The tingling in her feet is much less and she no longer feels unsteady in the dark. Her endoscopy three and a half weeks ago showed corpus-predominant atrophic gastritis with intestinal metaplasia and ECL-cell hyperplasia, no neuroendocrine tumor, dysplasia, or cancer, and no H. pylori; two small hyperplastic polyps were removed. She finished eight sessions of physical therapy last week and does her home program daily. Her back pain is better but flares after long days at the range. [S]
| Element | Detail |
|---|---|
| Interval change | Energy normal; tongue healed; tingling much less |
| Adherence | Four of four weekly injections given |
| Endoscopy | Autoimmune atrophic gastritis; no neuroendocrine tumor or neoplasia |
| Back pain | Better after eight therapy sessions; flares after long days at the range |
| Falls | None |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy normal; weight up 1.1 kg since the first visit |
| Respiratory | Negative | No breathlessness on stairs |
| Gastrointestinal | Negative | No indigestion, black stools, or bleeding after the endoscopy |
| Neurological | Positive | Occasional mild tingling of the toes; balance normal in the dark |
| Musculoskeletal | Positive | Low back pain after long standing |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once daily for seven days | 1000 micrograms IM daily for one week | Intramuscular route | 2026-02-10 to 2026-02-16 | completed | S |
| Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once weekly for four weeks | 1000 micrograms IM weekly for four weeks | Intramuscular route | 2026-02-17 to 2026-03-10 | completed | S |
| Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once a month, lifelong | 1000 micrograms IM once a month | Intramuscular route | 2026-04-06 | active | S |
| Ferrous sulfate 325 mg oral tablet (65 mg elemental iron), one tablet by mouth every other day with orange juice | One tablet every other day | Oral route | 2026-04-06 | active | S |
| Naproxen sodium 220 mg oral tablet, one tablet by mouth with food up to twice daily as needed for back pain flares | One tablet up to twice daily as needed with food | Oral route | 2026-04-06 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-06 | Body height | 152 | cm | S |
| 2026-04-06 | Body weight | 47.3 | kg | S |
| 2026-04-06 | Body mass index (BMI) [Ratio] | 20.5 | kg/m2 | S |
| 2026-04-06 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-04-06 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-04-06 | Heart rate | 76 | /min | S |
| 2026-04-06 | Respiratory rate | 14 | /min | S |
| 2026-04-06 | Body temperature | 36.6 | Cel | S |
| 2026-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-06 | Hemoglobin [Mass/volume] in Blood | 12.3 | g/dL | 11.6-15 g/dL | Normal | S |
| 2026-04-06 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 96 | fL | 80-100 fL | Normal | S |
| 2026-04-06 | Leukocytes [#/volume] in Blood by Automated count | 5.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-04-06 | Platelets [#/volume] in Blood by Automated count | 245 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-04-06 | Methylmalonate [Moles/volume] in Serum or Plasma | 0.28 | umol/L | <=0.4 umol/L | Normal | S |
| 2026-04-06 | Ferritin [Mass/volume] in Serum or Plasma | 14 | ng/mL | 30-400 ng/mL | Low | S |
| 2026-04-06 | Iron saturation [Mass Fraction] in Serum or Plasma | 11 | % | 20-50% | Low | S |
| 2026-04-06 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-04-06 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 2026-04-06 | Oswestry disability index score ODI | 22 | {score} | S |
Vital signs recorded on 2026-04-06; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well, good color |
| Mouth | Tongue normal |
| Neurological | Vibration reduced at the toes and normal at the ankles; proprioception normal; ankle reflexes present; Romberg negative |
| Back | Mild paraspinal tenderness; full strength; straight-leg raise negative; no saddle numbness |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Pernicious anemia with B12 deficiency neuropathy (reduced vibration and proprioception in the feet); synthetic modern diagnosis linked to the documented 1926 cause of death | active | confirmed | D51.0 | S — Synthetic diagnosis confirmed by B12, MMA, and intrinsic factor antibodies in the modern episode; the 1926 cause of death remains D as reported. |
| Chronic low back pain, mechanical, without radiculopathy; synthetic modern problem linked to the documented 1901 train collision and 1922 automobile accident | active | confirmed | M54.50 | S — Synthetic chronic pain problem; the back injury and the accident are documented, its modern characteristics are synthetic. |
| Autoimmune atrophic gastritis, corpus-predominant, with linear ECL-cell hyperplasia; no neuroendocrine tumor, dysplasia, or cancer; H. pylori negative | active | confirmed | K29.40 | S — Synthetic histologic diagnosis at endoscopy; the underlying cause of pernicious anemia. |
| Iron deficiency without anemia, unmasked by red cell recovery and reduced iron absorption in atrophic gastritis | active | confirmed | E61.1 | S — Synthetic finding at the eight-week review. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Blood count with MCV | Eight weeks after starting B12 replacement | Completed today | Hemoglobin 12.3 g/dL, MCV 96 fL, white cells 5.4, platelets 245: normal |
| Laboratory | MMA | One week to three months after starting replacement | Completed today | 0.28 micromol/L, normal, down from 2.10 |
| Laboratory | Iron studies | When red cell production recovers | Completed today | Ferritin 14 ng/mL, transferrin saturation 11 percent: iron deficiency |
| Laboratory | Serum B12 | Not routinely retested once replacement has begun | Not indicated | Not repeated |
| Examination | Neurologic examination (vibration, proprioception, gait, cognition) | At diagnosis and at follow-up visits for B12 deficiency with neurologic findings | Completed today | Improved: vibration reduced at the toes only; Romberg negative |
| Imaging | Upper endoscopy with topographic gastric biopsies | At diagnosis of pernicious anemia; surveillance by individual risk | Up to date | Done three and a half weeks ago; no neuroendocrine tumor or neoplasia; surveillance in about three years |
| Laboratory | H. pylori testing | Once in atrophic gastritis | Up to date | Negative on gastric biopsies |
| Imaging | Colonoscopy for iron deficiency | At diagnosis of iron deficiency in a postmenopausal woman | Ordered | To be booked within four weeks |
| Laboratory | Blood count after starting oral iron | About one month after starting oral iron | Due | In about four weeks |
| Survey | Back pain intensity and Oswestry Disability Index | Every visit while treating chronic low back pain | Completed today | Pain 4 of 10; Oswestry 22 percent |
| Survey | Depression screen (PHQ-2) | Periodically | Completed today | Score 0 |
| Self-management | Exercise therapy for back pain | Eight weeks, then a home program | Completed today | Eight sessions completed; home program daily; tai chi added |
| Medication safety | NSAID safety | When starting and at each visit | Completed today | Platelets 245 and eGFR 93; as-needed use with food only |
| Imaging | Lumbar spine imaging | Only with red flags or before an intervention | Not indicated | No red flags |
| Examination | Fall risk | Every visit while neuropathy persists | Completed today | Romberg negative; no falls |
Goal progress:
Guideline basis: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021); AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia (2020); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)
Follow-up: Monthly B12 injections with the practice nurse. Colonoscopy within four weeks. Blood count in about four weeks. Review in three months with blood count, iron studies, and back pain scores. Next scheduled visit 2026-07-06: five-month pernicious anemia, iron, neuropathy, and back pain review. [S]